Airsculpt Technologies, Inc. AIRS
Nasdaq · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2021-10-29
Airsculpt Technologies, Inc. statistics & valuation
Market cap$322.4M
P / S2.1×
P / B3.7×
P / FCF465.9×
Net margin-7.7%
Return on equity-13.3%
FCF margin0.5%
Net debt$47.6M
Net debt / EBITDA39×
Enterprise value USD$370.0M
Earnings yield EBIT/EV-3.1%
Return on capital-7.3%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating margin | -7.6% | -0.9% | 5.0% | -2.7% | 11.8% | 16.0% |
| Net margin | -7.7% | -4.4% | -2.2% | -8.7% | 7.9% | 12.1% |
| FCF margin | 0.5% | -1.5% | 7.2% | 6.8% | 14.6% | 16.4% |
| Return on assets | -6.2% | -3.8% | -2.1% | -7.3% | 5.3% | 4.2% |
| Return on equity | -13.3% | -10.3% | -5.1% | -20.7% | 12.6% | — |
| Debt / equity | 0.64× | 0.89× | 0.87× | 1.18× | 0.99× | — |
| Current ratio | 0.55 | 0.59 | 0.79 | 0.75 | 1.79 | 1.22 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.